Apeiron Labs, Inc. — Form D
Apeiron Labs, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-06-16. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Other Technology.
Offering
- Filed: 2022-06-16
- Form: D
- Accession: 0001933295-22-000002
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $5.0M
- Investors: 1
- Date of first sale: 2022-06-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-449469
Issuer
- Name: Apeiron Labs, Inc.
- CIK: 0001933295
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 486 GREEN STREET, CAMBRIDGE, MA, 02139
- Phone: 617-648-9362
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Jonathan Rosen | Executive Officer | Cambridge, MA |
| SANJEEV KRISHNAN | Director | Chicago, IL |
| Jonathan Rosen | Director | Cambridge, MA |
| David Douglas | Director | Vancouver, A1 |
| Kyle Teamey | Director | Markle, IN |
| Mark Abbott | Director | Cambridge, MA |
| Ravikanth Pappu | Director | Cambridge, MA |
| Ravikanth Pappu | Executive Officer | Cambridge, MA |
Other filings by this issuer (1)
More